UVA vs UVB Rays: What's the Difference and Why It Matters

Updated: September 7, 2026 | 15-minute read

Most people treat sunlight as the villain in skin aging — but the full picture of UVA ultraviolet light is more specific, and more actionable, than the blanket "avoid the sun" advice you've been given.

UVA ultraviolet light occupies the 315–400 nm band of the electromagnetic spectrum. It accounts for roughly 95% of the UV radiation that reaches Earth's surface, and compared with its shorter-wavelength cousin UVB, a greater proportion of UVA can penetrate into the dermis — the skin's deeper structural layer — where it can contribute to oxidative stress, collagen damage, and photoaging. Cloud cover does not completely block UVA, although the actual exposure level varies with weather and solar conditions. That greater depth of penetration is what makes UVA biologically distinct, not merely "more of the same."

What follows works through the full picture: how UVA interacts with skin at the cellular level, where genuine health risks lie versus overstated fears, and — critically for anyone evaluating light therapy devices — why well-engineered phototherapy panels operate entirely outside the UV band. By the end, you'll have the framework to read any product's spectral data and know immediately whether UV exposure is a real concern.

This article is for general education. It does not replace medical advice, individualized phototherapy guidance, or the safety instructions and labeling for a specific device.

What UVA ultraviolet light actually is — and where it sits in the spectrum

UVA ultraviolet light band highlighted in electromagnetic spectrum diagram

UVA ultraviolet light occupies the 315–400nm band — the longest-wavelength, lowest-energy subdivision of the ultraviolet range. Standard spectral definitions used by organizations such as the CIE, ISO 21348:2007, ICNIRP, and WHO divide UV into UVC from 100–280nm, UVB from 280–315nm, and UVA from 315–400nm. According to the World Health Organization, UVA accounts for roughly 95% of the UV radiation that actually reaches Earth's surface, because the atmosphere absorbs all solar UVC and most UVB before it arrives at ground level.

In the broader electromagnetic spectrum, UVA sits immediately below visible violet light at around 400nm. That placement matters for one clarification readers searching "uv vs uva rays" often need: UVA is non-ionizing. It carries far less energy per photon than X-rays or gamma radiation and cannot strip electrons from atoms the way ionizing radiation does — but "non-ionizing" is not the same as biologically inert. Photon energy does decrease as wavelength increases, so UVC carries the highest energy per photon among UV subtypes, UVB sits in the middle, and UVA carries the least. Even so, UVA's lower energy per photon is more than compensated by its abundance and its ability to penetrate deeper into tissue than its higher-energy relatives.

Therapeutic red light (roughly 620–700nm) and near-infrared light (700–1100nm) sit entirely outside the UV band — separated from UVA's upper boundary at 400nm by a clear spectral gap. These wavelengths are studied for photobiomodulation through cellular photochemical and photophysical pathways, including mitochondrial signaling and reactive oxygen species modulation. Those mechanisms differ from the DNA photoproducts and oxidative damage associated with excessive UV exposure. That distinction is the central thread this article follows.

A brief history of UVA's discovery

In 1801, the German physicist Johann Wilhelm Ritter detected invisible radiation beyond the violet end of the visible spectrum — radiation that caused silver chloride to darken faster than visible light did. This was an early documented observation of ultraviolet radiation, although the experiment did not spectrally separate the modern UVA and UVB bands. The subdivision of the UV band into UVA, UVB, and UVC came much later, as photobiology developed through the twentieth century and researchers began mapping which wavelength ranges produced which biological effects.

Early photobiology research concentrated on UVB. Its role in triggering vitamin D3 synthesis in skin and its direct responsibility for sunburn gave it obvious clinical relevance. UVA attracted less attention partly because its effects are slower and harder to observe acutely. That changed as epidemiological data on skin aging, melanoma incidence, and occupational UV exposure accumulated across decades. Scientists recognized that cumulative UVA exposure was reshaping collagen architecture and driving pigmentation changes in ways distinct from UVB's acute damage.

The International Commission on Non-Ionizing Radiation Protection (ICNIRP) formalized occupational and public exposure guidelines that address UVA specifically, and the WHO's adoption of the UV Index as a global public health tool represented another milestone. The UV Index is based on erythemally weighted UV radiation; shorter UVB wavelengths receive much greater weighting, but UVA still contributes to the underlying spectrum and is not represented as a separate UVA dose.

How UVA penetrates skin and what it does at the cellular level

Cross-section diagram showing UVA ultraviolet light vs UVB skin penetration depth

Common belief: UVB is the UV type you need to worry about because it causes sunburn, while UVA is mild background radiation you can largely ignore.

What's actually true: UVB causes sunburn, but UVA reaches deeper tissue — and the damage it causes accumulates silently over years before it becomes visible.

Because UVA is generally less strongly absorbed by epidermal chromophores than UVB, a greater proportion can pass through the epidermis and reach the dermis, where collagen fibers, fibroblasts, and blood vessels reside. Within UVA, UVA2 is commonly described as 315–340nm and UVA1 as 340–400nm; UVA1 generally penetrates deeper, while UVA2 has biological behavior closer to shorter-wavelength UV. These are broad categories rather than fixed tissue boundaries, and actual depth depends on tissue composition, pigmentation, and optical conditions. UVB, with its shorter wavelength and higher photon energy, is absorbed mainly in the epidermis — which helps explain its strong role in acute erythema.

UVA damages cells through two primary pathways. The first is direct DNA interaction, producing cyclobutane pyrimidine dimers, though at lower efficiency than UVB. The second — and dominant — mechanism is indirect: UVA excites photosensitizing chromophores within skin cells, generating reactive oxygen species (ROS) that then attack DNA, proteins, and lipid membranes. It's this oxidative cascade, documented extensively in Photochemistry and Photobiology literature, that drives the photoaging fingerprint of wrinkle formation, elastin degradation, and uneven pigmentation — changes that accumulate without any single day of visible burning.

One practical point from public-health guidance is that some UVA can pass through ordinary glass and cloud cover does not completely block UV. The amount varies with the type of glass, glazing or film, cloud thickness, solar angle, and location. Sitting near a window for several hours, or driving on an overcast day, can therefore deliver UVA exposure despite the absence of any sensation of sun exposure.

UVA and eye health

The deeper penetration issue extends to the eye. Unlike UVB, which is largely absorbed by the cornea and lens and is implicated in acute photokeratitis, some UVA can pass farther into the eye and reach the lens; only a small fraction may reach the retina. UV exposure has been associated with cataract and other eye risks, but the effect depends on wavelength, dose, duration, and exposure geometry. ICNIRP exposure-limit guidelines address ocular UVA dose as a distinct concern from surface skin exposure. For anyone evaluating a light-based device used near the face, the relevant risk question is not simply "does it emit UV?" but "what wavelengths, at what dose, reach the eye?"

The international photobiological safety standard IEC 62471:2006 evaluates photobiological hazards from electrically powered broadband optical sources across 200–3000nm, including specific UV hazards to skin and eyes at defined measurement conditions. When a light therapy device has an IEC 62471 report, the relevant hazard results, exposure limits, measurement distance, and risk group should be checked directly. That report is more specific for photobiological safety than a general CE mark alone, but it does not by itself mean that the device has zero UV emission.

Solar UVA and the UV index

Common belief: A low UV Index means low UV exposure risk across the board.

What's actually true: The UV Index is weighted toward erythemally effective radiation, with much greater weighting given to shorter UVB wavelengths than to UVA. It is useful for assessing sunburn-related UV risk, but it does not provide a separate measurement of the day's UVA dose.

UVA intensity often varies less with solar angle and season than UVB does, although it still changes with weather, atmosphere, latitude, and time of day. In practical terms, UVA can contribute across more hours and more months of the year, even at temperate latitudes. Combined with the fact that some UVA can pass through window glass, this means indoor workers near windows may accumulate additional lifetime UVA exposure while believing they have been fully protected from sun damage. This is one reason broad-spectrum sunscreen claims address both UVA and UVB rather than relying on SPF alone.

Human health effects of UVA: separating risk from fear

Person applying broad-spectrum sunscreen outdoors to protect against UVA ultraviolet light

Ordinary incidental UVA exposure may not produce immediate symptoms, but sufficiently high UVA exposure can contribute to erythema, phototoxic reactions, eye effects, and DNA damage. The risk is both dose-dependent and cumulative: lifetime UVA exposure is a well-established contributor to photoaging and contributes to skin-cancer risk, including melanoma, through oxidative and other forms of DNA damage and immune effects. WHO identifies excessive UV exposure overall as a major cause of skin cancer; the relative contribution of UVA and UVB varies by endpoint and exposure pattern.

The question "which is worst — UVA or UVB?" doesn't have a clean answer without context. UVB photons carry more energy, interact more efficiently with DNA, and receive much higher weighting in the erythema action spectrum used in dermatological risk models. In a typical surface solar spectrum, UVA is much more abundant than UVB and penetrates deeper on average, but the ratio changes with location, season, weather, and solar angle. Neither type is uniformly "worst" — they produce different damage patterns across different tissue depths and exposure conditions.

One distinction matters for readers beginning to explore therapeutic light: UVB can initiate the synthesis of pre-vitamin D3 in skin, the step that begins the photochemical cascade leading to the active hormone form. This does not mean that deliberate UVB exposure is required, because vitamin D can also come from diet and supplements. UVA provides no established essential requirement comparable to vitamin D synthesis. Protective behavior directed at UV reduction does not require seeking UVA exposure.

Effective protection involves layering measures rather than relying on any single approach.

1. Choose broad-spectrum sunscreen. SPF primarily reflects protection against UV-induced erythema and is much more influenced by UVB than UVA. A broad-spectrum formulation can also attenuate UVA; avobenzone and zinc oxide are common UVA-protective ingredients, while the UVA coverage of titanium dioxide depends on the formulation and wavelength range. Check for explicit "broad spectrum" labeling or a locally recognized UVA protection indicator — neither is guaranteed by SPF alone.

2. Apply UV-blocking window film for extended indoor exposure. Ordinary glass blocks most UVB but may transmit a meaningful amount of UVA, especially in parts of the UVA1 range. For offices or vehicles where window proximity is unavoidable for hours each day, a verified UV-blocking film can reduce the transmitted UVA dose substantially.

3. Wear protective clothing for extended outdoor work. Tightly woven fabrics and garments rated with an Ultraviolet Protection Factor (UPF) block both UV subtypes — the EPA and WHO both include clothing as a primary UV protective measure.

4. Recognize elevated-exposure sources beyond the sun. Tanning beds commonly emit high-intensity UVA together with some UVB and represent a higher-concern artificial exposure category. Certain industrial UV lamps used in printing or curing can produce occupationally significant UVA doses; many sterilization systems, by contrast, use UVC and require a different hazard assessment.

Blockers, absorbers, and UVA-transmitting materials

Standard glass is one of the more counterintuitive examples of selective UV transmission. It blocks most UVB, while the amount of UVA transmitted depends on glass composition, thickness, coatings, and the wavelength. For someone sitting near a sun-facing window for five to six hours daily, the resulting UVA exposure may be relevant over months and years, but the dose should not be assumed without measuring the glazing and exposure conditions.

Broad-spectrum sunscreen filters work through absorption, scattering, reflection, or a combination of these mechanisms depending on the active ingredient, particle size, and formulation. Avobenzone absorbs UVA photons; zinc oxide can provide broad UVA attenuation; titanium dioxide is generally stronger in shorter UV wavelengths and its UVA coverage depends on the formulation. The important practical point is that SPF alone does not provide a separate UVA rating. A high-SPF sunscreen without adequate broad-spectrum UVA protection may leave substantial UVA exposure unaddressed.

These same material science principles carry into device design. Polycarbonate lenses, UV-stabilized optical plastics, and purpose-designed UV-blocking filters may be used in protective eyewear or optical assemblies. For a light-emitting device, however, the relevant claim should be based on measured spectral output and photobiological hazard limits, not an absolute statement of zero UV leakage.

Why legitimate phototherapy devices are engineered entirely outside the UV band

Wavelength comparison chart: UVA ultraviolet light at 315–400nm versus red 660nm and NIR 850nm therapy

Photobiomodulation (PBM) — a proposed mechanism underlying some red and near-infrared light applications — is commonly studied within approximately the 600–1100nm range, where photons may interact with mitochondrial and other cellular chromophores, including cytochrome c oxidase. This mechanism remains an active area of research and is fundamentally different from the dominant DNA-photoproduct and oxidative-damage mechanisms associated with excessive UV exposure. PBM wavelengths at 660nm and 850nm may influence cellular energy metabolism and signaling, including reactive oxygen species modulation; the outcome depends on wavelength, dose, irradiance, timing, and tissue.

Operating outside the UV band does not make every red or near-infrared device automatically risk-free. High-output visible or near-infrared sources may cause glare, visual discomfort, heating, or other eye hazards depending on irradiance, distance, exposure time, and device geometry. Users should follow product labeling, avoid staring directly into high-output LEDs, and seek professional advice when they have a photosensitivity disorder or use photosensitizing medication.

The spectral gap between UVA and therapeutic red light is not marginal. The nearest therapeutic red wavelength at 660nm sits 260nm above UVA's upper boundary at 400nm. A device emitting 660nm and 850nm light is not "close" to the UV band in any meaningful sense — the two regions are as different spectrally as visible red is from ultraviolet. A device can deliver both UV and red or near-infrared light only if UV-emitting components or other UV sources are present, so the product's spectral test data should be checked rather than inferred from marketing language.

The verification framework for this includes IEC 62471:2006, the international photobiological safety standard that evaluates optical hazards across the relevant wavelength range and classifies applicable emissions into Exempt/RG0, RG1, RG2, or RG3 according to exposure limits. For UV hazard, the report should identify the measured spectral range, exposure distance, exposure duration, skin and eye hazard results, and any required controls. RG2 is not automatically equivalent to unsafe use, nor does RG1 mean that a product emits no UV. A CE mark alone does not confirm IEC 62471 results; the specific test report and risk group classification must be reviewed.

Manufacturing-process improvements, such as replacing adapted wiring components with series-specific dedicated wiring, may reduce material waste, hidden labor, and assembly variation. These improvements can support manufacturing consistency, but they do not by themselves prove photobiological safety. That safety still requires product-specific spectral measurement and risk assessment in addition to design controls, component selection, inspection steps, and assembly-process controls.

What wavelengths are actually used in evidence-based light therapy

Two commonly studied wavelength ranges in PBM research are visible red, roughly 630–680nm, and near-infrared, roughly 800–880nm. Red light is often studied for superficial tissue applications, while near-infrared light can penetrate more deeply under some optical conditions. Actual penetration and biological response depend on wavelength, tissue composition, geometry, irradiance, exposure time, and device design; a wavelength alone does not establish a clinically relevant depth or outcome.

How manufacturers verify and document zero UVA emission

IEC 62471 testing evaluates relevant optical emissions, including UV hazards, by applying the applicable action spectra and exposure limits under defined measurement conditions. It uses four risk groups: Exempt/RG0, Risk Group 1 (low), Risk Group 2 (moderate), and Risk Group 3 (high). A therapy device used near skin or eyes should be assessed according to its intended use, exposure distance, exposure time, labeling, and hazard-specific results. An Exempt or RG1 result for a particular UV hazard does not mean “no UV output”; it means the measured hazard is within the corresponding limit under the stated conditions.

Here is how a responsible manufacturer implements and documents that process:

1. Internal testing at the component and finished-product stage. Spectrometers, irradiance meters, and integrating spheres can be used during development and production to characterize spectral output and irradiance. Any claim that a device has no measurable UV component should state the instrument range, detection limit, test distance, calibration status, and measurement conditions. Company-specific laboratory and inspection-process claims should be supported by current internal records or published test documentation.

2. Third-party IEC 62471 testing and risk group classification. A competent third-party laboratory measures the relevant optical hazards at defined distances and issues a test report with the applicable risk-group classification. Buyers should request the IEC 62471 report, including the product model, operating mode, measurement distance, exposure conditions, hazard results, and risk group — not rely only on a general CE declaration.

3. Compliance documentation made available to buyers. ETL listing where applicable, CE technical documentation, FDA registration/listing records, FCC compliance documentation, and RoHS declarations each address different requirements. For UV hazard specifically, buyers should confirm that a relevant IEC 62471 test report is available and review the hazard-specific result rather than treating an Exempt or RG1 classification as proof of zero UV.

The practical takeaway: when evaluating any light-emitting wellness device, request the IEC 62471 test report alongside the relevant CE, FCC, RoHS, or FDA documentation. These documents address different conformity, electromagnetic, substance-restriction, or registration requirements; none should be treated as a universal efficacy or UV-free claim. The IEC 62471 report is the document to review for the device's measured photobiological hazards under stated conditions before it is used near eyes or skin.

When reading a device spectrum, check the peak wavelength and bandwidth, any short-wavelength or UV tail, spectral irradiance or irradiance at the stated working distance, measurement geometry, operating mode, calibration information, and the applicable eye, skin, and thermal hazard results. A wavelength label alone does not establish the complete optical output or safety profile.

Artificial sources of UVA: tanning beds, lamps, and common misunderstandings

Artificial UVA sources include tanning beds, black-light or fluorescence systems, some curing and inspection lamps, and certain dermatological phototherapy systems. Their safety cannot be judged from the word “UVA” alone: wavelength distribution, irradiance, exposure time, distance, shielding, intended use, and eye protection all matter. Tanning devices can emit high-intensity UVA together with UVB and are associated with skin, eye, and skin-aging risks. Medical UVA applications such as PUVA are controlled clinical procedures and should not be equated with recreational tanning.

• Sources for this section: WHO — Ultraviolet radiation and health, FDA — Risks of tanning, and IARC — Artificial UV radiation and skin cancer.

Key Takeaways

UVA ultraviolet light occupies the 315–400 nm band and, compared with UVB, can penetrate more deeply into the dermis — where it contributes to photoaging and skin-cancer risk through oxidative and other forms of DNA damage. Understanding that distinction matters practically: broad-spectrum sunscreens rated for both UVA and UVB protection, not SPF alone, are the appropriate defense against long-wave UV exposure. Therapeutic devices operating in the red (620–700 nm) and near-infrared (700–1100 nm) ranges sit well outside the UV spectrum entirely, making them a categorically different class of photobiomodulation research and light-based applications.

FAQ

Is UVA light bad for you?

UVA light can contribute to cumulative skin damage — photoaging, collagen degradation, and skin-cancer risk — even when exposure does not produce visible sunburn. According to the WHO, UVA constitutes roughly 95% of the UV radiation that reaches the Earth's surface, making it the dominant component of surface solar UV in many conditions. Unlike UVB, some UVA can penetrate ordinary glass, and clouds do not completely block UV, so indoor and overcast-day exposure may still accumulate. Controlled therapeutic applications of UVA do exist in dermatology, including PUVA therapy, but they are medically supervised and should not be equated with unprotected recreational exposure.

Which is most harmful, UVA or UVB?

The answer depends on which harm you're measuring: UVB is a major driver of sunburn and direct DNA photoproducts such as cyclobutane pyrimidine dimers, while UVA drives photoaging and penetrates deeper into skin tissue on average, contributing to skin-cancer risk through oxidative and other DNA damage pathways. The International Agency for Research on Cancer classifies relevant UV radiation and solar radiation exposures as carcinogenic to humans. In practical terms, neither is automatically "safe" — they cause different types of damage, which is why both must be addressed in sun protection.

Do humans need UVA or UVB?

UVB photons in approximately the 290–315 nm range can trigger vitamin D synthesis in the skin, but humans do not need deliberate UV exposure to obtain vitamin D because dietary sources and supplements are available. UVA does not meaningfully contribute to vitamin D production. There is no established physiological requirement for UVA exposure, though it can stimulate melanin production — the skin's own protective response to UV.

Is UVA the worst UV?

UVC (100–280 nm) carries the highest photon energy among the three conventional UV bands and can be highly hazardous at sufficient exposure, but solar UVC is absorbed by the atmosphere before normally reaching Earth's surface. Of the UV that reaches humans from ordinary sunlight, UVA is the highest-volume component, and its ability to penetrate deeper into skin without always causing immediate sunburn means damage can accumulate unnoticed — which makes it arguably one of the most underestimated risks in everyday life.

References

• World Health Organization (WHO). Ultraviolet radiation and health.
• WHO. The known health effects of ultraviolet radiation.
• ISO 21348:2007. Process for determining solar irradiances.
• IEC 62471:2006. Photobiological safety of lamps and lamp systems.
• U.S. Environmental Protection Agency (EPA). Ultraviolet radiation and sun exposure.
• U.S. Food and Drug Administration (FDA). Ultraviolet radiation and tanning.
• FDA. Important reminders about device registration and listing.
• European Commission. CE marking for manufacturers.
• IARC. Artificial UV radiation and skin cancer.
• UVA1 phototherapy review — PubMed.
• FDA. Photobiomodulation devices — draft premarket guidance.
• Photobiomodulation review — PubMed.

Related Guides

Related guides on uva ultraviolet light therapy and wavelength science

Understanding UVA ultraviolet light is only the starting point. The broader science of UV vs UVA rays, therapeutic wavelengths, and device safety connects across a range of more detailed topics — the guides below help you build a complete picture, whether you're evaluating devices, researching wavelength biology, or comparing light therapy options.

1. UVA vs UVB wavelength breakdown — how the biological effects diverge across the 280–400 nm range, from surface tanning to DNA photoproduct formation at shorter wavelengths.
2. UVC disinfection and germicidal applications — why UVC (100–280 nm) is used in sterilization contexts and why solar UVC is normally absorbed before reaching Earth's surface.
3. Visible red light (660 nm) and near-infrared (850 nm) therapy — how photons at these wavelengths are studied in photobiomodulation and differ from the DNA-photoproduct and oxidative-damage mechanisms associated with excessive ultraviolet exposure.
4. UV vs UVA rays in sunscreen and skin protection labeling — what "broad-spectrum" actually means and how SPF ratings address UVA penetration specifically.
5. Device safety standards for therapeutic light — covering IEC 62471 photobiological safety classifications, EMC compliance, and why reputable panels specify wavelength output rather than UV content.
6. Ultraviolet light examples across industries — from forensic detection and currency verification to medical phototherapy, where UV application is tightly controlled by dosage and wavelength.

The distinction between UV bands and therapeutic visible or near-infrared light is not semantic — it helps determine which optical hazards and regulatory requirements need to be assessed. Devices like red and near-infrared therapy panels can operate entirely outside the UV spectrum, but their actual output should be confirmed by spectral and photobiological testing. CE marking, FCC compliance, FDA registration/listing, and IEC 62471 assessment address different requirements; none should be used alone to imply clinical utility, FDA approval, or zero UV emission.